Literature DB >> 17361387

Infusions of rocuronium and cisatracurium exert different effects on rat diaphragm function.

Dries Testelmans1, Karen Maes1, Patrick Wouters2, Scott K Powers3, Marc Decramer1, Ghislaine Gayan-Ramirez4.   

Abstract

OBJECTIVE: Aminosteroidal and benzylisoquinoline neuromuscular blocking agents are used in the intensive care unit to facilitate mechanical ventilation. The use of these agents has been associated with development of critical illness myopathy; however, the relative frequency of myopathy development among agents is not known. The aim of our study was to compare the effects of 24 h infusion of rocuronium or cisatracurium on the diaphragm in mechanically ventilated rats.
DESIGN: Randomized, controlled experiment.
SETTING: Basic animal science laboratory.
SUBJECTS: Male Wistar rats, 14 weeks old.
INTERVENTIONS: Rats were divided into four groups to receive either saline, rocuronium (low dose) or cisatracurium (low or high dose). MEASUREMENTS AND
RESULTS: After 24 h, in vitro diaphragm tetanic force was decreased after rocuronium (-33% vs. saline), while the force was more preserved after cisatracurium, even in the high-dose group. Cross-sectional areas of the different diaphragm and gastrocnemius fibers were unaltered. Diaphragmatic MURF-1 mRNA was increased after rocuronium (+44% vs. saline), while unchanged in both cisatracurium groups. Calpain activity was increased after rocuronium (+75% vs. saline) and unchanged in the cisatracurium groups. MURF-1 mRNA expression and calpain activity were negatively correlated with diaphragm force.
CONCLUSIONS: Cisatracurium infusion during controlled mechanical ventilation exerted less detrimental effects on diaphragm function and proteolytic activity than infusion of rocuronium, even with the higher effective dose. These data suggest that increased calpain activity and increased activation of the ubiquitin proteasome system play a role in the different effects of these agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361387     DOI: 10.1007/s00134-007-0584-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  40 in total

Review 1.  Disorders of the respiratory muscles.

Authors:  Franco Laghi; Martin J Tobin
Journal:  Am J Respir Crit Care Med       Date:  2003-07-01       Impact factor: 21.405

2.  Prolonged (more than ten hours) neuromuscular blockade after cardiac surgery: report of two cases.

Authors:  Lori Olivieri; Gilles Plourde
Journal:  Can J Anaesth       Date:  2005-01       Impact factor: 5.063

3.  Neuromuscular blockade in the intensive care unit.

Authors:  L C Gehr; C N Sessler
Journal:  Semin Respir Crit Care Med       Date:  2001       Impact factor: 3.119

4.  Effects of short vs. prolonged mechanical ventilation on antioxidant systems in piglet diaphragm.

Authors:  Samir Jaber; Mustapha Sebbane; Christelle Koechlin; Maurice Hayot; Xavier Capdevila; Jean-Jacques Eledjam; Christian Prefaut; Michèle Ramonatxo; Stefan Matecki
Journal:  Intensive Care Med       Date:  2005-07-22       Impact factor: 17.440

Review 5.  The ubiquitin-proteasome system and skeletal muscle wasting.

Authors:  Didier Attaix; Sophie Ventadour; Audrey Codran; Daniel Béchet; Daniel Taillandier; Lydie Combaret
Journal:  Essays Biochem       Date:  2005       Impact factor: 8.000

6.  Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression.

Authors:  Moin U Fareed; Amy R Evenson; Wei Wei; Michael Menconi; Vitaliy Poylin; Victoria Petkova; Bernadette Pignol; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-02-02       Impact factor: 3.619

Review 7.  The new neuromuscular blocking agents: do they offer any advantages?

Authors:  E W Moore; J M Hunter
Journal:  Br J Anaesth       Date:  2001-12       Impact factor: 9.166

Review 8.  Brief review: Nondepolarizing neuromuscular blocking drugs and critical illness myopathy.

Authors:  Michael J Murray; Sorin J Brull; Charles F Bolton
Journal:  Can J Anaesth       Date:  2006-11       Impact factor: 5.063

Review 9.  Sedation, analgesia, and neuromuscular blockade for high-frequency oscillatory ventilation.

Authors:  Curtis N Sessler
Journal:  Crit Care Med       Date:  2005-03       Impact factor: 7.598

Review 10.  Complications associated with sedative and neuromuscular blocking drugs in critically ill patients.

Authors:  R C Prielipp; D B Coursin; K E Wood; M J Murray
Journal:  Crit Care Clin       Date:  1995-10       Impact factor: 3.598

View more
  18 in total

Review 1.  [Diaphragm dysfunction : Facts for clinicians].

Authors:  C S Bruells; G Marx
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-10-20       Impact factor: 0.840

2.  Rationale and design of a mechanistic clinical trial of JAK inhibition to prevent ventilator-induced diaphragm dysfunction.

Authors:  Joseph B Shrager; Yoyo Wang; Myung Lee; Shannon Nesbit; Winston Trope; Harrison Konsker; Emmanuel Fatodu; Mark S Berry; George Poulstides; Jeffrey Norton; Thomas Burdon; Leah Backhus; Roger Cooke; Huibin Tang
Journal:  Respir Med       Date:  2021-09-21       Impact factor: 3.415

Review 3.  Bench-to-bedside review: Diaphragm muscle function in disuse and acute high-dose corticosteroid treatment.

Authors:  Catherine Sh Sassoon; Vincent J Caiozzo
Journal:  Crit Care       Date:  2009-09-08       Impact factor: 9.097

Review 4.  Ventilator-induced diaphragm dysfunction: the clinical relevance of animal models.

Authors:  Theodoros Vassilakopoulos
Journal:  Intensive Care Med       Date:  2007-10-11       Impact factor: 17.440

Review 5.  Prolonged mechanical ventilation alters diaphragmatic structure and function.

Authors:  Scott K Powers; Andreas N Kavazis; Sanford Levine
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

Review 6.  [Ventilator-induced diaphragm dysfunction : clinically relevant problem].

Authors:  C S Bruells; G Marx; R Rossaint
Journal:  Anaesthesist       Date:  2014-01       Impact factor: 1.041

7.  The effect of rocuronium, sugammadex, and their combination on cardiac muscle and diaphragmatic skeletal muscle cells.

Authors:  Yildiray Kalkan; Habib Bostan; Levent Tumkaya; Yakup Tomak; Mehmet Bostan; Adnan Yilmaz; Hasan Turut; Ahmet Temiz; Alper Yalçin; Alparslan Turan
Journal:  J Anesth       Date:  2012-07-14       Impact factor: 2.078

Review 8.  Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production.

Authors:  Scott K Powers; Malcolm J Jackson
Journal:  Physiol Rev       Date:  2008-10       Impact factor: 37.312

Review 9.  Critical illness-associated diaphragm weakness.

Authors:  Martin Dres; Ewan C Goligher; Leo M A Heunks; Laurent J Brochard
Journal:  Intensive Care Med       Date:  2017-09-15       Impact factor: 17.440

10.  A fresh look at paralytics in the critically ill: real promise and real concern.

Authors:  David Price; Nicholas J Kenyon; Nicholas Stollenwerk
Journal:  Ann Intensive Care       Date:  2012-10-12       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.